Sunitinib in Patients with Cisplatin-Refractory Germ Cell Tumors

Publisher： Karger

E-ISSN： 2296-5262|35|7-8|455-456

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.35, Iss.7-8, 2012-07, pp. : 455-456

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Salvage Chemotherapy with Paclitaxel, Ifosfamide, and Cisplatin (TIP) in Relapsed or Cisplatin-Refractory Germ Cell Tumors

By  

Oncology Research and Treatment, Vol. 34, Iss. 8-9, 2011-08 ,pp. : 416-420

Karger

Access to resources Recommend Favorite

Final Report of the First Refractory Germ Cell Tumor Treated with Sunitinib Malate

By  

Case Reports in Oncology, Vol. 2, Iss. 3, 2009-12 ,pp. : 234-241

Karger

Access to resources Recommend Favorite

Brief Report: Phase II Multicenter Study of Temozolomide in Patients with Cisplatin-Resistant Germ Cell Tumors

By  

Oncology, Vol. 80, Iss. 3-4, 2011-07 ,pp. : 219-222

Karger

Access to resources Recommend Favorite

Risk-Adapted Chemotherapy of Germ Cell Tumors with Carboplatin, Etoposide and Bleomycin for Low-Risk and Cisplatin, Etoposide and Ifosfamide for High-Risk Patients

By  

Oncology, Vol. 59, Iss. 2, 2000-08 ,pp. : 110-117

Karger

Access to resources Recommend Favorite

Gonadal Function in Patients with Testicular Germ Cell Tumors

By Tomomasa H.   Oshio S.   Ashizawa Y.   Kamiyama Y.   Okano Y.   Iiyama T.   Sato S.   Shimizu H.   Umeda T.  

Archives of Andrology, Vol. 48, Iss. 6, 2002-11 ,pp. : 405-415

Informa Healthcare

Access to resources Recommend Favorite